If Biogen (BIIB) can capitalize on this biosimilar opportunity, it may have a positive impact on BIIB stock and on the Health Care Select Sector SPDR ETF (XLV). Biogen comprises ~2.3% of XLV’s total portfolio holdings. On …
Drive
Biogen Inc. BIIB, a well-known name in the multiple sclerosis (MS) market, will be reporting fourth-quarter 2016 and full-year earnings on Jan 26, before the market opens.Last quarter, the company delivered a positive …
Biogen Idec
Overall, call buying has been a popular strategy among BIIB options traders, with the stock's 10-day call/put volume ratio across the ISE, CBOE, and PHLX seated at 1.47. On the other hand, near-term traders are more …
Trader
The company posted revenue of $2872.00 million in the period, compared to analysts expectations of $2939.36 million. At the moment 25 analysts are watching Biogen Inc. These holdings make up 91.62% of the …
The share price of Biogen Inc. (NASDAQ:BIIB) tumbled as much as 8 percent, to $395, Friday after sales of …
Q1
After the session commenced at $46.79, the stock reached the higher end at $47.32 while it ... Medtronic, Novartis, and Biogen Idec.
Alnylam Pharmaceuticals, Inc.
94 BIIB up +0.45% percent Today $BIIB Stock High is Lucky Jimmy 01/08/2016 11:10:35 AM 93 BIIB up +1.24% percent Today $BIIB Stock High is Lucky Jimmy 01/05/2016 10:35:23 AM 92 BIIB up +1.25% …
Stock rating for biopharmaceutical company Biogen Inc. (NASDAQ:BIIB) was maintained as Market Perform by analyst Geoffrey Porges at Leerink Partners. The reiteration in the rating came after company’s disclosure of …
TCC4mon
But for investors looking for a more aggressive growth opportunity, these stocks aren’t it. Over the last five years, BIIB stock has gained 621%. It now trades at $347 per share. AMGN is up 198% in the same time, and each …
Delta Air Lines Inc. Stock Market Ratings by StockPickReport.com for Merck & Co, Micromuse, 8x8, …